Alexander J. Najibi
Alexander J. Najibi
Ph.D. Student, Harvard University
Email yang diverifikasi di g.harvard.edu - Beranda
Judul
Dikutip oleh
Dikutip oleh
Tahun
A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
NJ Shah, AJ Najibi, TY Shih, AS Mao, A Sharda, DT Scadden, DJ Mooney
Nature biomedical engineering 4 (1), 40-51, 2020
372020
CD4 T-cells regulate angiogenesis and myogenesis
BJ Kwee, E Budina, AJ Najibi, DJ Mooney
Biomaterials 178, 109-121, 2018
292018
Acetalated dextran nanoparticles loaded into an injectable alginate cryogel for combined chemotherapy and cancer vaccination
T Bauleth‐Ramos, TY Shih, MA Shahbazi, AJ Najibi, AS Mao, D Liu, ...
Advanced Functional Materials 29 (35), 1903686, 2019
252019
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ...
Nature communications 11 (1), 1-14, 2020
242020
Treating ischemia via recruitment of antigen-specific T cells
BJ Kwee, BR Seo, AJ Najibi, AW Li, TY Shih, D White, DJ Mooney
Science advances 5 (7), eaav6313, 2019
162019
Cell and tissue engineering in lymph nodes for cancer immunotherapy
AJ Najibi, DJ Mooney
Advanced Drug Delivery Reviews, 2020
112020
Ultrasound-triggered release reveals optimal timing of CpG-ODN delivery from a cryogel cancer vaccine
TY Shih, AJ Najibi, AL Bartlett, AW Li, DJ Mooney
Biomaterials, 121240, 2021
2021
Abstract PO085: Cryogel-based cancer vaccine to treat acute myeloid leukemia
AJ Najibi, NJ Shah, TY Shih, AS Mao, A Sharda, DT Scadden, DJ Mooney
Cancer Immunology Research 9 (2 Supplement), PO085-PO085, 2021
2021
Abstract B045: Antigen-free cancer vaccine to treat poorly immunogenic tumors
MC Sobral, H Wang, AJ Najibi, A Li, CS Verbeke, DJ Mooney
Cancer Immunology Research 7 (2 Supplement), B045-B045, 2019
2019
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–9